SAN DIEGO, June 15 /PRNewswire/ -- Enterprise Partners Venture Capital, a leading Southern California venture capital firm focusing on the life sciences and technology, announced today that Kleanthis G. Xanthopoulos, Ph.D., will join the firm by year-end as a Managing Director, after completing his transition from Anadys Pharmaceuticals (Nasdaq: ANDS - News), a biopharmaceutical company he founded in 2000 and where he currently serves as President and Chief Executive Officer. He will remain on the Anadys Board of Directors.
